| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $57K | +1414.0% |
| Cost of Revenue | $3.9M | — |
| Gross Profit | -$3.9M | — |
| R&D Expense | $14.5M | +11.5% |
| SG&A Expense | $14.3M | +15.4% |
| Operating Income | -$48.7M | -91.8% |
| Net Income | -$49.8M | -82.7% |
| EPS (Basic) | -$59.81 | -8962.1% |
| EPS (Diluted) | -$59.81 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $2.1M | -85.7% |
| Inventory | $110K | +0.0% |
| Current Assets | $2.8M | -86.6% |
| Total Assets | $3.7M | -87.3% |
| Current Liabilities | $16.0M | +68.4% |
| Total Liabilities | $16.8M | -15.3% |
| Stockholders' Equity | -$13.1M | -245.5% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$30.1M | -26.4% |
| Capital Expenditures | $161K | -94.3% |
| Investing Cash Flow | -$161K | +95.9% |
| Financing Cash Flow | $17.6M | -11.3% |
| Free Cash Flow | -$30.3M | -13.5% |
| -8962.1% |